查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1971127

醫療設備軟體市場分析及預測（至2035年）：類型、產品類型、服務、技術、組件、應用、部署類型、最終用戶、功能、解決方案

Software as a Medical Device Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Deployment, End User, Functionality, Solutions
出版日期: | 出版商: Global Insight Services | 英文 375 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

軟體即醫療設備(SaMD) 市場預計將從 2024 年的 573 億美元成長到 2034 年的 3,209 億美元，複合年成長率約為 18.8%。軟體即醫療器材 (SaMD) 市場涵蓋旨在獨立於硬體執行醫療功能的軟體解決方案。這些應用能夠診斷、監測和治療疾病，並提供進階分析和即時數據洞察。由於法規結構的不斷完善、個人化醫療的需求以及人工智慧和機器學習技術的融合，SaMD 解決方案正日益受到關注。在數位醫療日益普及和對以患者為中心的創新醫療解決方案的需求推動下，該市場呈現出成長勢頭。

在數位醫療技術進步和監管支援的推動下，醫療器材軟體（SaMD）市場持續穩定成長。慢性病盛行率的上升以及對遠端患者監護需求的成長，使得診斷和監護軟體在性能方面處於主導。針對心理健康和慢性病管理的治療軟體也緊隨其後，反映出對個人化治療方案日益成長的需求。行動應用程式憑藉其易用性和便利性，正獲得顯著的市場認可，而雲端平台則因其可擴展性和整合能力而備受青睞。人工智慧（AI）驅動的SaMD解決方案正成為提高診斷準確性和預測分析能力的關鍵趨勢。與現有醫療保健系統的互通性至關重要，它有助於實現無縫資料交換並改善患者預後。為了因應人們對資料隱私和保護的擔憂，網路安全措施方面的投資正在不斷增加。監管合規性和對臨床檢驗的重視仍然是重中之重，以確保SaMD解決方案的安全性和有效性。

市場區隔
類型 診斷、治療和監測軟體
產品 行動應用、穿戴式裝置軟體、雲端解決方案、桌面應用、Web解決方案、內建軟體
服務 諮詢服務、實施服務、訓練及支援服務、維護服務
科技 人工智慧、機器學習、區塊鏈、物聯網 (IoT)、巨量資料分析、雲端運算、擴增實境、虛擬實境
成分 軟體平台、軟體工具、軟體庫
應用 慢性病管理、遠端患者監護、醫學影像、數位療法
實施表格 本機部署、雲端部署、混合式部署
最終用戶 醫療服務提供者、病患、臨床研究機構、製藥公司
功能 資料管理、病患管理、臨床決策支援、遠端醫療
解決方案 互通性解決方案、安全解決方案、合規性解決方案、資料分析解決方案

市場概況：

軟體即醫療設備(SaMD) 市場的市場動態特徵是市場佔有率波動、定價策略競爭激烈以及新產品層出不窮。為了滿足日益成長的數位醫療技術需求，市場正朝著更複雜、更人性化的解決方案轉型。各公司正致力於將人工智慧和機器學習技術融入創新，以增強產品功能。在北美和歐洲等醫療基礎設施發達的地區，SaMD 的普及率顯著，而新興市場正逐步迎頭趕上。這種情況催生了一個競爭激烈的市場環境，各公司都在尋求透過獨特的價值主張和策略聯盟來實現差異化。隨著現有企業和新參與企業爭奪市場主導地位，SaMD 市場的競爭日益激烈。基準研究表明，主要企業正在大力投資研發，以保持其競爭優勢。監管機構，特別是美國食品藥物管理局(FDA) 和歐盟委員會的影響力，對塑造市場動態至關重要。遵守嚴格的監管標準至關重要，各公司將產品品質和安全性放在首位。監管環境不斷演變，重點在於確保病患安全和資料安全，這給市場參與企業帶來了挑戰和機遇，他們需要應對複雜的法規結構，並將創新解決方案推向市場。

主要趨勢和促進因素：

在技​​術進步和監管支援的推動下，軟體定義醫療設備(SaMD) 市場正經歷變革性成長。關鍵趨勢包括將人工智慧 (AI) 和機器學習技術應用於診斷，以提高診斷準確性和個人化治療。這些技術能夠實現即時數據分析，從而改善患者預後並提高營運效率。此外，穿戴式裝置和行動醫療應用的廣泛應用也拓展了 SaMD 解決方案的應用範圍。消費者對遠端監測和遠距遠端醫療服務的需求不斷成長，也推動了這一趨勢。監管機構在製定明確的指導方針和框架方面發揮關鍵作用，這些方針和框架既促進了創新，也保障了病人安全。向價值醫療模式的轉變也是一個重要的促進因素，因為相關人員正在尋求能夠帶來卓越療效且成本效益高的解決方案。此外，慢性病盛行率的不斷上升也對創新數位醫療解決方案提出了更高的要求，進一步推動了 SaMD 市場的發展。對於能夠開發擴充性、互通性且能與現有醫療系統無縫整合的平台的公司而言，存在著眾多機會。

限制與挑戰：

醫療器材軟體（SaMD）市場面臨許多重大限制與挑戰。監管的複雜性仍然是一大障礙，企業需要投入大量資源和專業知識才能應對各種全球標準。這種監管負擔會延緩產品上市，增加企業成本，並阻礙市場擴張。資料安全和隱私問題也是重大挑戰。 SaMD應用通常處理敏感的患者訊息，因此強大的網路安全措施至關重要。資料外洩可能會削弱消費者信任，並導致嚴重的法律後果，從而阻礙企業採用這項技術。互通性問題也阻礙了市場成長。 SaMD解決方案必須與現有醫療保健系統無縫整合，但技術和標準的差異使這一過程變得複雜。實現相容性需要大量投資和先進的技術能力。此外，科技的快速發展需要持續創新。為了保持競爭力，企業必須在研發方面投入大量資金，從而加劇財務壓力。最後，隨著新參與企業和老牌企業爭奪市場主導，市場競爭日益激烈。這種競爭格局迫使企業進行差異化，這往往會導致激進的定價策略。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 診斷軟體
    • 治療軟體
    • 監控軟體
  • 市場規模及預測：依產品分類
    • 行動應用
    • 穿戴式裝置軟體
    • 基於雲端的解決方案
    • 桌面應用程式
    • 網路為基礎的解決方案
    • 嵌入式軟體
  • 市場規模及預測：依服務分類
    • 諮詢服務
    • 實施服務
    • 培訓和支援服務
    • 維護服務
  • 市場規模及預測：依技術分類
    • 人工智慧
    • 機器學習
    • 區塊鏈
    • 物聯網 (IoT)
    • 巨量資料分析
    • 雲端運算
    • 擴增實境（AR）
    • 虛擬實境
  • 市場規模及預測：依組件分類
    • 透過軟體平台
    • 軟體工具
    • 軟體庫
  • 市場規模及預測：依應用領域分類
    • 慢性病管理
    • 遠端患者監護
    • 醫學影像診斷
    • 數位療法
  • 市場規模及預測：依發展狀況
    • 本地部署
    • 基於雲端的
    • 混合
  • 市場規模及預測：依最終用戶分類
    • 醫療保健提供者
    • 病人
    • 臨床研究所
    • 製藥公司
  • 市場規模及預測：依功能分類
    • 資料管理
    • 病患管理
    • 臨床決策支持
    • 遠端醫療
  • 市場規模及預測：按解決方案分類
    • 互通性解決方案
    • 安全解決方案
    • 合規解決方案
    • 數據分析解決方案

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Zebra Medical Vision
  • Viz.ai
  • Qure.ai
  • Aidoc
  • Aidence
  • HeartFlow
  • Arterys
  • iSchemaView
  • CureMetrix
  • Imbio
  • Ultromics
  • Oxipit
  • Therapixel
  • Lunit
  • Quantib

第9章：關於我們

簡介目錄
Product Code: GIS34281

Software as a Medical Device Market is anticipated to expand from $57.3 billion in 2024 to $320.9 billion by 2034, growing at a CAGR of approximately 18.8%. The Software as a Medical Device (SaMD) Market encompasses software solutions designed to perform medical functions independently of hardware. These applications diagnose, monitor, and treat diseases, offering advanced analytics and real-time data insights. With regulatory frameworks evolving, SaMD solutions are gaining traction, driven by the need for personalized healthcare and the integration of AI and machine learning technologies. The market is poised for growth, influenced by increased digital health adoption and the demand for innovative, patient-centric care solutions.

The Software as a Medical Device (SaMD) Market is experiencing robust expansion, fueled by advancements in digital health technologies and regulatory support. Diagnostic and monitoring software leads in performance, driven by the rising prevalence of chronic diseases and the demand for remote patient monitoring. Therapeutic software, addressing mental health and chronic condition management, follows closely, reflecting the increasing need for personalized treatment solutions. Mobile applications, offering ease of use and accessibility, are gaining significant traction, while cloud-based platforms are preferred for their scalability and integration capabilities. Artificial Intelligence (AI)-powered SaMD solutions are emerging as a key trend, enhancing diagnostic accuracy and predictive analytics. The interoperability of SaMD with existing healthcare systems is crucial, promoting seamless data exchange and improved patient outcomes. Investment in cybersecurity measures is rising, addressing concerns over data privacy and protection. The emphasis on regulatory compliance and clinical validation remains paramount, ensuring the safety and efficacy of SaMD solutions.

Market Segmentation
TypeDiagnostic Software, Therapeutic Software, Monitoring Software
ProductMobile Applications, Wearable Device Software, Cloud-Based Solutions, Desktop Applications, Web-Based Solutions, Embedded Software
ServicesConsulting Services, Implementation Services, Training and Support Services, Maintenance Services
TechnologyArtificial Intelligence, Machine Learning, Blockchain, Internet of Things (IoT), Big Data Analytics, Cloud Computing, Augmented Reality, Virtual Reality
ComponentSoftware Platforms, Software Tools, Software Libraries
ApplicationChronic Disease Management, Remote Patient Monitoring, Medical Imaging and Diagnostics, Digital Therapeutics
DeploymentOn-Premise, Cloud-Based, Hybrid
End UserHealthcare Providers, Patients, Clinical Research Organizations, Pharmaceutical Companies
FunctionalityData Management, Patient Management, Clinical Decision Support, Telemedicine
SolutionsInteroperability Solutions, Security Solutions, Compliance Solutions, Data Analytics Solutions

Market Snapshot:

Software as a Medical Device (SaMD) market dynamics are characterized by evolving market shares, competitive pricing strategies, and a surge in new product launches. The market is witnessing a shift towards more sophisticated, user-friendly solutions that cater to the growing demand for digital health technologies. Companies are focusing on innovation, integrating AI and machine learning to enhance functionalities. Regions with advanced healthcare infrastructure, such as North America and Europe, are seeing significant adoption rates, while emerging markets are gradually catching up. This landscape is fostering a competitive environment where companies strive to differentiate through unique offerings and strategic partnerships. Competition in the SaMD market is intensifying, with established players and new entrants vying for market dominance. Benchmarking reveals that leading firms are investing heavily in R&D to maintain a competitive edge. Regulatory influences, particularly from the FDA and European Commission, are pivotal in shaping market dynamics. Compliance with stringent regulatory standards is crucial, driving companies to prioritize quality and safety in their offerings. The regulatory landscape is evolving, with a focus on ensuring patient safety and data security. This creates both challenges and opportunities for market participants, as they navigate complex regulatory frameworks to bring innovative solutions to market.

Geographical Overview:

The Software as a Medical Device (SaMD) market is flourishing globally, with distinct regional dynamics. North America leads, driven by technological innovation and robust regulatory frameworks supporting SaMD adoption. The presence of leading tech companies and significant healthcare investments further propel the market. Europe follows, with strong regulatory support and a focus on patient safety and data privacy. The region's commitment to healthcare innovation fosters a conducive environment for SaMD growth. In Asia Pacific, the market is expanding rapidly, fueled by increasing healthcare digitization and supportive government initiatives. Countries like China and India are emerging as key growth pockets, driven by large patient populations and rising healthcare demands. Latin America and the Middle East & Africa are nascent markets with growing potential. In these regions, increasing healthcare investments and digital transformation efforts are opening new opportunities for SaMD adoption.

Key Trends and Drivers:

The Software as a Medical Device (SaMD) market is experiencing transformative growth driven by technological advancements and regulatory support. Key trends include the integration of artificial intelligence and machine learning to enhance diagnostic accuracy and treatment personalization. These technologies enable real-time data analysis, improving patient outcomes and operational efficiency. Furthermore, the proliferation of wearable devices and mobile health applications is expanding the reach of SaMD solutions. This trend is supported by increasing consumer demand for remote monitoring and telehealth services. Regulatory bodies are also playing a pivotal role by establishing clear guidelines and frameworks that facilitate innovation while ensuring patient safety. The shift towards value-based healthcare is another significant driver, as stakeholders seek cost-effective solutions that deliver superior outcomes. Additionally, the growing prevalence of chronic diseases necessitates innovative digital health solutions, further propelling the SaMD market. Opportunities abound for companies that can develop scalable, interoperable platforms that seamlessly integrate with existing healthcare systems.

Restraints and Challenges:

The Software as a Medical Device (SaMD) market encounters several significant restraints and challenges. Regulatory complexities remain a formidable obstacle, as navigating diverse global standards demands substantial resources and expertise. This regulatory burden can delay product launches and inflate costs for companies, hindering market expansion. Data security and privacy concerns pose another critical challenge. SaMD applications often handle sensitive patient information, necessitating robust cybersecurity measures. Breaches can erode consumer trust and result in severe legal repercussions, deterring potential adopters. Interoperability issues also impede market growth. SaMD solutions must seamlessly integrate with existing healthcare systems, yet disparate technologies and standards complicate this process. Achieving compatibility requires considerable investment and technical prowess. Furthermore, the rapid pace of technological advancement creates a continuous need for innovation. Companies must invest heavily in research and development to stay competitive, straining financial resources. Finally, market competition intensifies as new entrants and established players vie for dominance. This competitive landscape pressures companies to differentiate their offerings, often leading to aggressive pricing strategies.

Key Players:

Zebra Medical Vision, Viz.ai, Qure.ai, Aidoc, Aidence, HeartFlow, Arterys, iSchemaView, CureMetrix, Imbio, Ultromics, Oxipit, Therapixel, Lunit, Quantib

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Functionality
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Diagnostic Software
    • 4.1.2 Therapeutic Software
    • 4.1.3 Monitoring Software
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Mobile Applications
    • 4.2.2 Wearable Device Software
    • 4.2.3 Cloud-Based Solutions
    • 4.2.4 Desktop Applications
    • 4.2.5 Web-Based Solutions
    • 4.2.6 Embedded Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting Services
    • 4.3.2 Implementation Services
    • 4.3.3 Training and Support Services
    • 4.3.4 Maintenance Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Artificial Intelligence
    • 4.4.2 Machine Learning
    • 4.4.3 Blockchain
    • 4.4.4 Internet of Things (IoT)
    • 4.4.5 Big Data Analytics
    • 4.4.6 Cloud Computing
    • 4.4.7 Augmented Reality
    • 4.4.8 Virtual Reality
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software Platforms
    • 4.5.2 Software Tools
    • 4.5.3 Software Libraries
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Chronic Disease Management
    • 4.6.2 Remote Patient Monitoring
    • 4.6.3 Medical Imaging and Diagnostics
    • 4.6.4 Digital Therapeutics
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 On-Premise
    • 4.7.2 Cloud-Based
    • 4.7.3 Hybrid
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Healthcare Providers
    • 4.8.2 Patients
    • 4.8.3 Clinical Research Organizations
    • 4.8.4 Pharmaceutical Companies
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Data Management
    • 4.9.2 Patient Management
    • 4.9.3 Clinical Decision Support
    • 4.9.4 Telemedicine
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Interoperability Solutions
    • 4.10.2 Security Solutions
    • 4.10.3 Compliance Solutions
    • 4.10.4 Data Analytics Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Deployment
      • 5.2.1.8 End User
      • 5.2.1.9 Functionality
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Deployment
      • 5.2.2.8 End User
      • 5.2.2.9 Functionality
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Deployment
      • 5.2.3.8 End User
      • 5.2.3.9 Functionality
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Deployment
      • 5.3.1.8 End User
      • 5.3.1.9 Functionality
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Deployment
      • 5.3.2.8 End User
      • 5.3.2.9 Functionality
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Deployment
      • 5.3.3.8 End User
      • 5.3.3.9 Functionality
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Deployment
      • 5.4.1.8 End User
      • 5.4.1.9 Functionality
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Deployment
      • 5.4.2.8 End User
      • 5.4.2.9 Functionality
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Deployment
      • 5.4.3.8 End User
      • 5.4.3.9 Functionality
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Deployment
      • 5.4.4.8 End User
      • 5.4.4.9 Functionality
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Deployment
      • 5.4.5.8 End User
      • 5.4.5.9 Functionality
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Deployment
      • 5.4.6.8 End User
      • 5.4.6.9 Functionality
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Deployment
      • 5.4.7.8 End User
      • 5.4.7.9 Functionality
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Deployment
      • 5.5.1.8 End User
      • 5.5.1.9 Functionality
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Deployment
      • 5.5.2.8 End User
      • 5.5.2.9 Functionality
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Deployment
      • 5.5.3.8 End User
      • 5.5.3.9 Functionality
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Deployment
      • 5.5.4.8 End User
      • 5.5.4.9 Functionality
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Deployment
      • 5.5.5.8 End User
      • 5.5.5.9 Functionality
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Deployment
      • 5.5.6.8 End User
      • 5.5.6.9 Functionality
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Deployment
      • 5.6.1.8 End User
      • 5.6.1.9 Functionality
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Deployment
      • 5.6.2.8 End User
      • 5.6.2.9 Functionality
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Deployment
      • 5.6.3.8 End User
      • 5.6.3.9 Functionality
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Deployment
      • 5.6.4.8 End User
      • 5.6.4.9 Functionality
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Deployment
      • 5.6.5.8 End User
      • 5.6.5.9 Functionality
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Zebra Medical Vision
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Viz.ai
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Qure.ai
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Aidoc
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Aidence
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 HeartFlow
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Arterys
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 iSchemaView
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 CureMetrix
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Imbio
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Ultromics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Oxipit
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Therapixel
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Lunit
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Quantib
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us